Literatur
- 1
Egan C A, Grant W J, Morris S E. et al .
Plasmapheresis as an adjunct treatment
of toxic epidermal necrolysis.
J Am Acad Dermatol.
1999;
40
458-461
- 2
Frangogiannis N G, Boridy I, Mazhar M. et al .
Cyclophosphamide in the treatment of toxic
epidermal necrolysis.
South Med J.
1996;
89
1001-1003
- 3
Halebian P H, Madden M R, Finklestein J L. et al .
Improved burn center survival of patients
with toxic epidermal necrolysis managed without corticosteroids.
Ann
Surg.
1986;
204
503-511
- 4
Höger P H.
Topische
Antibiotika und Antiseptika.
Hautarzt.
1998;
49
331-347
- 5 Konstantinow A, Balda B R, Mühlbauer W. Management
of toxic epidermal necrolysis. Abstract für das »Congresso
Interregionale Nord-Est« der »Società Italiana
di Dermatologia e Venerologia«,. Riccione 1993
- 6
Lebargy F, Wolkenstein P, Gisselbrecht M. et al .
Pulmonary complications in toxic epidermal
necrolysis: A prospective clinical study.
Intensive Care
Med.
1997;
23
1237-1244
- 7
Mc Gee T, Münster A.
Toxic epidermal
necrolysis syndrome.
Plast Reconstr Surg.
1998;
102
1018-1022
- 8
Meneux E, Paniel B J, Pouget F. et al .
Vulvovaginal sequelae in toxic epidermal
necrolysis.
J Reprod Med.
1997;
42
153-156
- 9
Paquet P, Pierard G E.
Would cyclosporin
A be beneficial to mitigate drug-induced toxic epidermal necrolysis?.
Dermatology.
1999;
198
198-202
- 10
Redondo P, de Felipe I, de la Pena A. et al .
Drug-induced hypersensitivity syndrome
and toxic epidermal necrolysis. Treatment with N-acetylcysteine.
Br
J Dermatol.
1997;
136
645-646
- 11 Ring J. Angewandte
Allergologie. MMW Medizin, München 1992: 244-254
- 12 Roujeau J C. Treatment
of SJS and TEN. In: Kauppinen K et al. (eds): Skin reactions
to drugs CRC Press, Boca Raton 1998: 141-150
- 13
Sanwo M, Nwadiuko R, Beall G.
Use
of intravenous immunoglobulin in the treatment of severe cutaneous
drug reactions in patients with AIDS.
J Allergy Clin Immunol.
1996;
98
1112-1115
- 14
Tegelberg-Stassen M J, van Vloten W A, de la Baart F aille
H.
Management of nonstaphylococcal toxic epidermal
necrolysis: Follow-up study of 16 case histories.
Dermatologica.
1990;
180
124-129
- 15
Viard J, Wehrli P, Bullani R. et al .
Inhibition of toxic epidermal necrolysis
by blockade of CD95 with human intravenous globulin.
Science.
1998;
282
490-493
1 Teil 1: Diagnostik erschien im vorherigen Heft (Nr. 6)
Korrespondenz
Dr. A. Konstantinow
Klinik und Poliklinik für Dermatologie und Allergologie
am Biederstein
Biedersteinerstraße 29
80802 München
